TV News Teams Cover Talcum Powder Cancer Lawsuits

The $72 million talcum powder ovarian cancer judgment handed down by a St. Louis jury has sparked TV news segments around the country covering the baby powder lawsuits.

Wednesday, March 23, 2016 - Local TV news outlets around the country have started producing stories on talcum powder ovarian cancer lawsuits. As baby powder cancer lawsuit news spread following a $72 million talcum powder cancer payout awarded in St. Louis, the attention baby powder lawsuits have received has grown around the country. The talcum powder cancer judgement reached in the City of St. Louis Circuit Court raised talcum powder cancer awareness and set a precedent for future talcum powder lawsuits brought against baby powder manufacturers.

A local news affiliate in Atlanta released a talcum powder cancer story on March 21 that covered a series of statistics related to the talcum powder lawsuits. The story referenced a number of baby powder cancer statistics, such as the 33 percent increase in ovarian cancer risk talcum powder can pose, and that studies researching talcum powder cancer trends have been ongoing since the 1970's. The story also covers the talcum powder cancer judgment handed down in St. Louis that awarded a deceased plaintiff $72 million in punitive and compensatory damages, a figure that has spurred much of the media attention talcum powder ovarian cancer links have received recently.

Baby powder cancer lawsuit news also came from a TV news affiliate in Cleveland, which produced a video segment March 21 chronicling the impact of the talcum powder cancer verdict and the story of plaintiff Jacqueline Fox. The story presents interviews with talcum powder cancer lawsuit attorney Jim Onder and Fox's son Marvin, who represented the plaintiff following her passing in October. Onder said that J&J had been aware of this "day of reckoning" for years, while Fox expressed his hope that the talcum powder cancer verdict would go on to help more women receive damages for the detrimental effect ovarian cancer has on their lives.

Both of the news outlets mentioned that the talcum powder ovarian cancer science remains unconfirmed and that J&J maintains their products are not associated with the disease. However, there was a new baby powder ovarian cancer study published in the medical journal Epidemiology that claims some of the dissociative talcum powder ovarian cancer evidence presented by J&J may be explained by menopausal links concerning the baby powder ovarian cancer link. The study found that a talcum powder ovarian cancer connection was only present in premenopausal women and those who were taking specific postmenopausal hormones.

There are currently more than 1,200 talcum powder ovarian cancer lawsuits pending around the country, with a lion's share of those filed in St. Louis and New Jersey. More than 100 talcum powder cancer lawsuits were recently consolidated into multicounty litigation in New Jersey, where J&J is headquartered. The fate of many of these talcum powder cancer lawsuits rested on the baby powder cancer judgment handed down by a City of St. Louis Circuit Court jury in February, and the $72 million talcum powder payout will go a long ways toward legitimizing future claims in litigation. In addition to the talcum powder lawsuits currently pending around the country, stories aired by TV news outlets similar to those in Cleveland and Atlanta will help raise awareness and likely spur a growth in talcum powder ovarian cancer lawsuits filed nationwide.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.